Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States
-- Approval Based on Clinically Meaningful Overall Survival Benefit Demonstrated in the TROPiCS-02 Study in Pre-Treated HR+/HER2- Metastatic Breast Cancer vs. Physician’s Choice of Chemotherapy...
2Q Revenue growth of 7% year-over-year; Organic revenue growth* of 9% 2Q Net income attributable to GE HealthCare of $418 million versus $485 million for the prior year, Adjusted EBIT* of $711...
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 -- HUTCHMED Limited ; class='js-l-obf link link--blue'
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the Center for Drug